NewsBenzingaNewAmsterdam Pharma Announces Dosing Of First Participant In SPINOZA, Phase 2b Clinical Trial Evaluating Obicetrapib In Individuals With Preclinical Alzheimer’s Disease NewAmsterdam Pharma Announces Dosing Of First Participant In SPINOZA, Phase 2b Clinical Trial Evaluating Obicetrapib In Individuals With Preclinical Alzheimer’s Disease Benzinga 2026.09.29 12:03 (GMT+0) Open on Benzinga Other news Amazon.com, Cleveland-Cliffs, Disc Medicine, Silence Therapeutics and EyePoint: Why These 5 Stocks Are on Investors' Radars Today Fifth Third Bancorp (FITB) Q3 2026 Earnings Call Transcript W. R. Berkley Corporation (WRB) Q3 2026 Earnings Call Transcript ServisFirst Bancshares, Inc. (SFBS) Q3 2026 Earnings Call Transcript ICICI Bank Limited (IBN) Q2 2027 Earnings Call Transcript US CFTC Rebuts CME's Standing to Sue, Says It Failed to Prove Harm from New Perpetual Contract Policy
Amazon.com, Cleveland-Cliffs, Disc Medicine, Silence Therapeutics and EyePoint: Why These 5 Stocks Are on Investors' Radars Today
US CFTC Rebuts CME's Standing to Sue, Says It Failed to Prove Harm from New Perpetual Contract Policy
